October 4, 2002
Cohen and coauthors, however, found evidence suggesting that HIV genotyping is less effective at predicting children's response to treatment. The researchers analyzed therapy outcomes for 18 children who underwent viral genotyping after failing to respond to their initial HAART regimen. Participants underwent a progress review every three months for one year after genotyping.
Ten patients changed HAART regimens after HIV genotyping, but none of these patients achieved a virologic response to their altered therapy, study data showed. By contrast, one of the eight children who maintained the original regimen after genotyping showed a durable reduction in viral load one year later.
In two-thirds of the children studied, HIV genotyping revealed viral resistance mutations to drugs with which they had not yet been treated.
Their report, "Response to Changes in Antiretroviral Therapy After Genotyping in Human Immunodeficiency Virus-Infected Children," was published in Pediatric Infectious Disease Journal (2002;21(7):647-653).
09.16.02; Michael Greer
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.